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Background and objective: Bacillus spp. with potent fibrin digesting enzymes, especially 
Bacillus subtilis (natto), has gained favorable insights into the world of cardiovascular health 
and functional foods. In this study, Bacillus subtilis G8 was isolated from Japanese fermented 
Natto soybean commercialized in Indonesia. The overall activity of Bacillus subtilis G8 in 
resolving blood clot was evaluated under variable conditions quantitatively using clot lysis 
assay. 
Material and methods: Cell-free crude extracts of Bacillus subtilis G8 culture were partially 
purified with acetone precipitation method. Fibrinolytic activity of the epnzymes was verified 
using fibrin plate assay and zymography. The measurement of clot liquefying activity under 
physiological temperature and pH was performed using chicken blood. The measurement of 
clot liquefying activity under physiological temperature and pH was performed using chicken 
blood. The measurement of clot liquefying activity under physiological temperature and pH 
was performed using chicken blood. 
Results and conclusion: Through zymography, Bacillus subtilis G8 expressed four bands of 
fibrinolytic proteins sized 19 to 30 kDa. Under controlled conditions, a significantly higher 
clot lysis was seen at 37 and 40°C, compared to lower temperatures (P≤0.05). In contrast, no 
significant decrease was seen in blood clot at all tested pH (P>0.05). These findings support 
the use of functional foods for the prevention of blood clot or as a part of blood health 
restoration. 
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In general, discovery of potent and affordable 
thrombolytic agents is important to prevent and treat 
thrombophilia and hence to decrease cardiovascular risks. 
The existing treatment of thrombophilia includes invasive 
interventions or use of antiplatelet and anticoagulant 
agents, as well as fibrinolytic enzymes. [1]. Unlike 
antiplatelet and anticoagulant agents that inhibit thrombus 
formations, fibrinolytic enzymes resolve and remove 
existing blood clots [2]. The currently available throm-
bolytic agents act as activators of plasminogen-plasmin 
system, including streptokinase, urokinase plasminogen 
activators and tissue plasminogen activators [3,4]. These 
chemicals are generally safe but costly [5,6].  
Potent microorganism genera with fibrinolytic activity 
have been assessed [1]. Discovery of Bacillus spp. with 
potent fibrin digesting enzymes brought additional 
favorable insights into the world of cardiovascular health 
and functional foods, especially Bacillus (B.) subtilis natto 
[7,8]. This bacterial species is widely known to produce 
enzymes with fibrinolytic properties. As purified enzymes 
are expensive, use of B. subtillis natto fermented products 
could be the most cost effective, feasible and safe 
alternative in prevention of undesired thrombus formation 
[9]. Generally, B. subtilis is recognized as safe used in 
various fermented soy-based products such as Japanese 
fermented natto (B. subtillis subs. natto) [10], Chinese 
traditional Douchi (B. subtilis DC33) [11], buckwheat 
Sokseongjang (B. subtilis HJ18-4) [12] and Chung-
kokjang/Doenjang (B. subtilis C5-1) [13]. Although natto-
kinases (approximate molecular weight of 27.7 kDa) have 
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been shown to include the majority of the fibrinolytic 
activity of B. subtilis, other enzymes have been identified 
as well [14]. Therefore, the current study further evaluated 
the overall activity of B. subtilis G8 from natto to resolve 
blood clot under a range of physiological conditions. 
Although quantitative clot lysis has extensively been used 
in drug assays such as purified streptokinases [15], no 
study has been carried out on functional foods intended for 
prevention of thrombophilia, or as a part of blood health 
restoration.  
In this study, in addition to assessing compatibility of 
thrombolysis activity from B. subtilis G8 under physio-
logical conditions, the present study validated the 
thrombolytic activity by microbial or probiotic isolates. 
Therefore, B. subtilis G8 was isolated from Japanese 
fermented natto commercialized in Indonesia. Chicken 
blood samples were used as they are inexpensive and 
easily obtainable. Results have indicated that thrombolytic 
studies using clotted chicken bloods provide a rapid, 
effective and efficient method for the overall clot-lytic 
effects of the B. subtilis G8 extracts isolated from Japanese 
fermented natto in Indonesia. 
2. Materials and methods 
Molecular identification of G8 isolate  
Bacteria were isolated from Japanese natto, commer-
cialized in Indonesia and streaked on nutrient agar. Total 
genomic DNA was extracted using Wizard Genomic DNA 
Purification Kit (Promega, USA). Then, 16S rRNA genes 
were amplified and sequenced for the molecular 
identification of B. subtilis G8. Polymerase chain reaction 
(PCR) was carried out in 50-μl reactions using universal 
primers of 27F (5′-AGAGTTTGATCMTGGCTCAG-3′) 
and 1492R (5′-GGTTACCTTGTTACGACTT-3′) (IDT, 
Singapore) and KAPA HiFi™ PCR Kit (Kapa Biosystems, 
USA). The initial denaturation step was carried out at 95°C 
for 3 min; followed by 25 cycles of denaturation at 98°C 
for 20 s, annealing at 55°C for 15 s and extension at 72°C 
for 60 s. A final extension step was carried out at 72°C for 
2 min. The PCR products were electrophoresed on agarose 
gels and visualized using gel documenting system. Then, 
16S rRNA PCR products were sent to 1st BASE 
Laboratories, Malaysia, for sequencing. The 16S rRNA 
partial sequences of the selected isolates were processed 
using Sequence Scanner Software v.2 (Applied 
Biosystems, USA) and BioEdit Software (Ibis 
Therapeutics, USA). These sequences were compared to 
those from NCBI GenBank database using BLAST 
algorithm (http://www.ncbi.nlm.nih.gov/BLAST/Blast. 
cgi). Phylogenetic analysis was carried out using MEGA X 
(Molecular Evolutionary Genetics Analysis).  
Protease and fibrin plate assays  
Agar well diffusion method was applied by inoculating 
cell-free supernatant on both protease and fibrin agar plate. 
Escherichia (E.) coli ATCC 8739 was used as negative 
control. Protease plates assay were conducted on skim milk 
agar plates (2% of skim milk and 1.5% of agar) and 
incubated at 37°C for 24 h upon introduction of 
supernatant. Formation of clear zones around the wells 
indicated extracellular protease Fibrin plates were prepared 
by adding 0.4% of fibrinogen in 1 M PBS (Sigma, USA) to 
an equal volume of 2% of agarose and 80 µl of 100 NIH 
unit/ml thrombin (Sigma, USA). Crude extracts of the G8 
isolate and E. coli ATCC 8739 were added into separate 
wells once the agarose solidified. Plates were incubated at 
37°C for 36 h [16].  
Partial purification of the enzyme 
The enzyme purification optimization was carried out 
by saturation adjustment of supernatants containing crude 
extracts using acetone (chilled at -20°C for 1 h.) 
The fractions were then centrifuged and dissolved in 
minimum volumes of pre-cold phosphate buffered saline 
(PBS, pH 7.4). Enzyme activities were measured through 
well diffusions on skim milk agar plates. Pure colony of B. 
subtilis was inoculated on 1 ml of nutrient broth and 
incubated at 37°C for 16 h using shaking incubator. 
SDS-PAGE and zymography 
Briefly, SDS-PAGE was carried out for the partially 
purified crude extracts of B. subtilis G8. Isolates were 
grown in NB overnight and centrifuged at 3,000 ×g for 5 
min. The supernatants containing crude extracts were 
adjusted to saturation using acetone (chilled at -20°C for 1 
h) at fractions of 1:3. These fractions were centrifuged and 
dissolved in minimum volumes of pre-cold PBS (pH 7.4) 
and then were analyzed using SDS-PAGE (including 12% 
of acrylamide). Furthermore, sample fibrin zymogram was 
carried out for the fibrin acrylamide gels by adding 0.006% 
(w v
-1
) of fibrinogen (Sigma, USA) and 50 µl of 100 NIH 
units ml
-1
 thrombin (MP Biomedicals, USA) to fibrin-
polyacrylamide solutions. Then, acrylamide gels were 
loaded with 10 μl of each sample and electrophoresis was 
carried out at a constant voltage of 50 mV for 1 h; the 
voltage was increased to 100 mV for the following hour. 
These gels were stained in Coomassie blue (0.5% of 
Coomassie blue, 40% of methanol and 10% of acetic acid 
glacial in dH2O) for 20 min, rinsed briefly in dH2O and 
destained twice for 1 h followed by overnight incubation in 
40% of methanol and 10% of acetic acid glacial solutions. 
Zones of clearance in gels corresponded to the presence of 
enzymes with fibrinolytic activities [17]. 
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In vitro blood clot lysis assay 
In general, a colony of the identified isolate was 
inoculated on 1 ml of NB and incubated at 37°C for 16 h 
using shaking incubator. Then, 1% of the isolate cultures, 
with OD600 values of 0.6-0.8, was added into 1 ml of fresh 
NB or soy broth (SB) (62 g of soybean powder l-1 in H2O) 
incubated at 37°C overnight using shaking incubator. 
Coagulated chicken blood was purchased from local 
markets and shifted into clots of 0.09-0.10 g each. Blood 
clot was then added into 1 ml of the media (with cultures 
or cell-free extracts). Mixtures were incubated at 37°C and 
visually studied at 0, 2, 4, 6 and 24 h [15]. 
Conditions affecting blood clot lysis 
A piece of 0.2 g retracted blood clot was added into 
solutions of 250 µl of 1 M sodium phosphate buffer (pH 
7.0) and 750 µl of cell-free crude extracts. Mixtures were 
then incubated under variable temperatures of 30, 35, 37 
and 40°C. To evaluate the effect of pH, clots were 
incubated at 37°C in cell-free crude extracts with variable 
pH values adjusted with 1 M phosphate buffer solutions to 
pH values of 6.4, 6.8, 7.0, 7.4, 7.8 and 8.0. The remaining 
clots were weighed after 4 h of incubation and dried at 
100°C for 20 min using oven. The relative clot lysis 
activity was calculated using Eq. 1: 
 
Relative blood clot lysis = 100% × (dry weight of blood clots 
before incubation) – dry weight of blood clots after incubation) / 
(dry weight of blood clots before incubation)                      Eq. 1 
Statistical analysis 
Statistical analysis was carried out for the clot 
reduction. Mean and standard deviation were calculated. 
Comparisons between the groups were carried out using 
analysis of variance test (ANOVA). Generally, P≤0.05 was 
considered as statistically significant. All statistical 
analyses were carried out using Minitab statistical software 
version 18. 
3. Results and discussion 
Bacterial verification 
In general, 16S rRNA gene partial sequencing of the 
isolates from the fermented natto produced 1,397 
nucleotides. The isolates were assigned as B. subtilis G8 
and the 16S rRNA gene sequences were annotated in 
GenBank database with the accession number of 
MH559564. BLAST results for 16S rRNA gene sequences 
from cultured isolates showed 100% identities with those 
for B. subtilis subsp. natto (KX279936). Sequence 
alignments of the 16S rRNA genes from B. subtilis G8 
with B. subtilis subsp. subtilis strain 168 (NR_102783) and 
B. subtilis subsp. natto BEST195 (NC_017196) showed a 
99% similarity. However, evolution analysis using 
phylogenetic tree suggested that B. subtilis G8 was closer 
to B. subtilis BEST195. Although, B. subtilis BEST195 
was reported to be closely linked to B. subtilis 168; 
however, they differently expressed favorable phenotypes 
for fermentation [18]. Furthermore, B. subtilis BEST195 
was claimed as the starter strain of natto commercialized 
and consumed in Japan [10,19]. The subtilisin NAT was 
demonstrated as an important enzyme contributing to the 
taste and flavor of natto as well as exhibiting fibrinolytic 
activities [20]. To better understand of fermenting profile 
and fibrinolytic activity of B. subtilis G8 subtilisin, 
selected loci must be analyzed using sequence typing, 
particularly apr genes which include regulatory regions 
[18,21] (Fig. 1). 
 
Figure 1. Phylogenetic tree of Bacillus subtilis G8 isolated from natto based on 16s rRNA sequences. The phylogenetic tree was 
constructed using Neighbor-joining method and MEGA X. The phylogram shows phylogenetic relationship between various Bacillus 
isolates based on the ribosomal 16S rRNA sequences. The scale bar represents 0.005 substitutions per site.
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Production of proteolytic and fibrinolytic enzymes by B. 
subtilis G8 was verified by the formation of clear zone 
around well on skim milk agar plates (Fig. 2A) and fibrin 
plates (Fig. B), respectively. 
 
Figure 2. Protease plate assay, cell-free supernatant were added 
onto wells made from skim milk agar plates (2% of skim milk 
and 1.5% of agar) and incubated at 37°C for 24 h (A); and fibrin 
plate assay, cell free supernatant were added onto wells made by 
adding 0.4% of fibrinogen in 1M phosphate-buffered saline 
(PBS) to equal volume of 2% of agarose and 80 µl of 100 
National Institute of Health (NIH) standard unit/ml of thrombin 
and incubated at 37°C for 36 h. (B). 
1) Escherichia coli ATCC 8739, 2) Bacillus subtilis G8.  
 
Identification of fibrinolytic enzymes 
To specifically identify production of fibrinolytic 
enzymes by B. subtilis G8, crude extracts of B. subtilis G8 
overnight cultures were partially purified using acetone 
precipitation 1:3 (v:v) and then were analyzed using SDS-
PAGE and zymography. Fibrin zymography of the 
partially purified samples showed a single band with 
molecular mass of approximately 19.1 kDa and three other 
weak bands of approximately 22.5, 27.5 and 29.3 kDa 
(Fig. 3). Normally, B. subtilis G8 produces fibrinolytic 
enzymes with various molecular weights as compared to 
other Bacillus spp. isolated from traditional foods such as 
oncom and gembus and B. subtilis isolated from jeotgal 
(small shrimp) [22,23].  
Size of nattokinase produced by B. subtilis subs. natto 
was previously reported as 27.7 kDa, which might be 
produced by B. subtilis G8 as demonstrated by one of the 
enzyme bands on zymogram [8]. 
Nattokinase, also known as subtilisin NAT, is encoded 
by aprN gene, which belongs to peptidase S8 family [20]. 
Another homologous gene which demonstrates similar 
properties to subtilisin N (aprN) and commonly found in 
B. subtilis is subtilisin E (aprE) [24]. The subtilisin (apr) 
genes have been reported in other Bacillus species, 
including subtilisin amylosacchariticus in B. subtilis subsp. 
amylosacchariticus [25,26] and subtilisin BPN and 
subtilisin Carlsberg in B. amyloliquefaciens and B. 
licheniformis, respectively [27-29].  
  
 
Figure 3. Coomassie blue stained SDS-PAGE gels (A) and fibrin 
zymograms (B) of the culture supernatants from Bacillus subtilis 
G8. Lane M) V8491 broad-range protein molecular weight 
markers; and Lane 1) Acetone partially purified crude extracts of 
Bacillus subtilis G8 grown overnight in nutrient broth at 37°C.  
 
Although B. subtilis G8 is predicted to express subtilisin 
(apr) protease with a similar fibrinolytic activity to that of 
nattokinase (aprN), more than one zymogram band 
indicates the presence of other enzymes that contribute to 
overall clot lysis activity. In addition to apr gene, 
fibrinolytic activity was demonstrated by vpr gene, which 
produces a mature protein of approximately 68 kDa. The 
vpr gene was shown to contain a nucleotide sequence 
similar to that from the active site of subtilisin [14]. There 
are more than one peptidase S8 (subtilisin-like serine 
proteases/subtilases) encoded by the B. subtilis genome 
(380-1500 amino acid residues). Individual isolation of 
these enzymes is necessary for a precise fibrinolytic 
enzyme profiling. The exact mechanisms of subtilases in 
the isolate need to be extensively characterized as these 
enzymes might play substantial roles in digestion of 
fibrins. 
Blood clot lysis assessment of B. subtilis  
Potential thrombolytic enzymes were assessed using in 
vitro models to study their clot lysis activity. The existing 
blood clot lysis assessment was commonly carried out for 
qualitative analysis [30]. Previous quantitative analysis 
was carried out based on the measurement of retracted clot 
weight before and after particular treatments [15]. 
However, retracted clots often swell when exposed to 
liquid enzyme treatments, contributing to errors that result 
in conflicted weight readings. In the current study, the 
existing method was further extended to measurement of 
blood clot dry weight, resulting in further precise and 
reliable measurements of the reduced clots before and after 
treatments. Although fibrinolysis activity varies among 
various species, use of chicken bloods in this study 
produced substantial reduction in clots [31,32].  
Two types of media were used for In vitro blood clot 
lysis. The growth medium was reported to affect not only 
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the growth rate but the fibrinolytic enzyme yields of a 
particular microorganism [33,34]. Previously, the main 
process in production of fibrinolytic enzymes involved 
soybean fermentation, which created a remarkable problem 
for both production and application of the enzymes [7]. 
The study first hypothesized that soy-based media could 
promote fibrinolytic activity of B. subtilis G8 from natto. It 
was reported that use of soy-based media could promote 
conversion of soy into functional ingredients with 
fibrinolytic enzymes [35,36]. However, relatively no 
differences were seen in both media (NB and SB). This 
suggests that other molecules with thrombolysis activity 
might be produced simultaneously, enhancing clot lysis 
regardless the involvement of soy fermentation. This 
suggests that other molecules with thrombolysis activity 
might be produced simultaneously, enhancing clot lysis 
regardless the involvement of soy fermentation. The blood 
clot lysis demonstrated by reduced blood clots was 
observed as early as 2 h in B. subtilis G8 broth cultures and 
6 h in centrifuged cell-free supernatants (Table 1A). 
Moreover, E. coli ATCC 8739 showed no reduced blood 
clot and supernatants remained clear (Table 1B). In 
addition to macroscopic clot lysis activity, microscopic 
analysis showed that red blood cells (RBC) preserved their 
integrity with no hemolysis after the assay (data not 
shown).  
Conditions affecting fibrinolysis activity  
In this study, clot lysis activity was assessed under 
various temperatures (30, 35, 37 and 40°C). Therefore, 
reduced blood clot progression remained stable through the 
temperatures. A significantly higher clot reduction was 
seen at 37 to 40°C, compared to that at 30°C (P≤0.05) (Fig. 
4).  
In contrast to temperature values, reduction of clots was 
constant for all pH values (pH 6.4-8.0). Normal physio-
logical pH of the human arterial blood includes 7.35-7.45, 
which is achieved by blood pH buffer potency. The highly 
strict blood pH values result in sustainable regulation of 
cellular activities ensuring human survival [37]. However, 
conditions such as metabolic abnormalities could result in 
pH changes above or below normal ranges [11]. The pH 
extremities for survival are reported around 6.8-7.8; other 
values are otherwise considered incompatible with normal 
health conditions. Extreme alkalosis in humans occurs 
mostly at pH 7.69 [38]; whereas extreme acidosis mainly 
occurs at pH 6.52 [39]. Patients with each condition 
experience extreme body distresses. In this study, ranges of 
pH tested on blood clot lysis activity stretched beyond pH 
extremities for survival (pH 6.4-8.0). 
 
Table 1. A) Blood lysis activity of overnight incubated Bacillus subtilis G8 soy broth and nutrient broth media with culture 
or centrifuged cell-free supernatants; B) Visual reference grading for blood lysis levels. 
A. Blood lysis activity 
Incubation time (h) Soy based media Nutrient broth media 
Broth culture media Cell-free supernatant Broth culture media Cell-free supernatant 
2 + - + - 
4 ++ - ++ - 
6 ++ + +++ + 
24 ++ ++ +++ ++ 
B. Visual reference grading 
No clot clearance Weak blood clot 
clearance 
Moderate blood clot 
clearance 
Absolute blood clearance 






   
Coagulated chicken bloods with concentrations of 0.1 g were added into 1 ml of the culture media (with culture or cell-free extracts). The 
mixtures were incubated at 37°C for the indicated time (2-24 h).  
No clot clearance (-), no color diffuse into supernatants and no changes in blood clot size; weak blood clot clearance (+), supernatants with 
light blood color and minimal changes in blood clot size; moderate blood clot clearance (++), supernatants with obvious blood color and 
decreases in blood clots; absolute blood clearance (+++), no blood clots left as blood clots were completely dissolved in the mixture. 
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Figure 4. Effects of all various temperatures (30-40°C) (A); and pH (6.4-8.0) incubated at 37°C for 4 h (B), on blood lysis 
activity of Bacillus subtilis G8 cell-free extracts. Results are expressed as mean±SD. Statistical analysis is calculated using 
ANOVA, different significant levels are denoted by different letters (a, b) (P≤0.05). 
 
 
Similar to these findings, working and optimal pH 
values of nattokinase extracted from B. subtilis var. natto 
B-12 were identified as 6.0-9.0 and pH 8.0, respectively. 
Thermostability of the nattokinase was observed at 
temperatures ranging from 30 to 50°C and its optimal 
activity at 40°C [29].  
This study utilized an in vitro model for the reduction 
clot lysis activity for potential thrombolytic drugs [15]. 
Although nattokinase has been reported as an enzyme that 
dominantly play a role in fibrinolytic activity by B. subtilis, 
other molecules of various molecular weights with 
thrombolysis activities are produced simultaneously, 
enhancing clot lysis process regardless the involvement of 
soy fermentation [22,29,40]. 
4. Conclusion 
In conclusion, the current study shows the presence of 
fibrinolytic activity of B. subtilis G8 from commercialized 
natto using fibrin plates and zymography. Clot lysis 
activity was seen throughout physiological blood 
conditions. These findings could support use of functional 
foods in prevention of thrombophilia or as a part of blood 
health restoration. 
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  چکیده 
هوای همو  نننوده )ناتو(، به علت محتووای آنوزی  باسیلوس سوبتیلیسویژه  های باسیلوس بهگونه سابقه و هدف:
باسویلوس انود  در ایون ملال،وه، بسیار شناخته شوده  1عروقی و مواد غذایی فراسودمند-از جنبه سالمت قلبی فیبرین
در رفو   G8باسویلوس سووبتیلیس از غذای تخمیری ژاپنی تجاری سویای ناتو جدا شد  ف،الیت نلی  G8 سوبتیلیس
 مشکل لخته خونی در شرایط مختلف با روش نافت لخته از نظر نمی مورد بررسی قرار گرفت 
طوور نسوبی  دهی بوا اسوتون بوه به روش رسوب G8باسیلوس سوبتیلیس  عصاره خام بدون سلول مواد و روش ها:
ها به روش پلیت فیبرین و زیموگرافی مورد تایید قرار گرفت  ایون روش بور تخلیص شد  ف،الیت فیبرینولیتیکی آنزی 
 های گوناگون انجام گرفت pHها و حرارت لخته خون جوجه در درجه
هوای های فیبرینولیتیک در اندازهپهنای پروتئین چهار G8باسیلوس سوبتیلیس زیموگرافی  گیری:و نتیجهها  یافته
درجوه  40 و 37هوای ای در درجوه حورارت نیلودالتون را نشان داد  تحت شرایط ننترل شده، نافت لخته 30تا  19
(  در مقابول، نواه p≤05/0داری بیشوتر بوود ) طوور م،نوی  تور بوه های پایینسلسیوس در مقایسه با درجه حرارت
ها اسوتااده از موواد (  این یافته05/0pهای مورد ملال،ه مشاهده نشد ) pHداری در لخته شدن خون در تمام  م،نی
 ننند غذایی فراسودمند را برای پیشگیری از لخته شدن خون یا به عنوان بخشی از بازیابی سالمت خون تایید می
 .ندارند مقاله این انتشار با مرتبط مناف،ی ت،ارض نوع هیچ نه ننند می اعالم نویسندگان تعارض منافع:
 واژگان کلیدی
 باسیلوس سوبتیلیس ▪
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